Costs outpace compensation
Newly released figures show that the running costs of the vaccine damage compensation scheme have surpassed £83 million, a total that is more than double the amount paid out to victims in compensation. The reported expenses cover administration and medical checks required to assess claims.
The disparity between operational spending and direct payments to claimants highlights the scheme’s overheads. Administration of claims and the medical assessments necessary to establish eligibility represent a significant portion of the budget for the programme, according to the figures.
The gap in spending on running the scheme versus payments to recipients may prompt further scrutiny from policymakers and public health officials debating the scheme’s efficiency and value for money. Observers say transparency about what drives administrative costs will be important for public confidence.
The figures do not change the programme’s stated aim of providing support to those who suffer rare adverse reactions to vaccines, but they do raise questions about the balance between processing capacity and the compensation delivered. Officials and stakeholders will likely review the numbers as part of ongoing oversight of the programme.